A5042598999- Oral health in cancer treatment
- Head and Neck Cancer Studies
- Cancer Diagnosis and Treatment
- Bone health and treatments
- Management of metastatic bone disease
- Bone and Joint Diseases
- Cancer Treatment and Pharmacology
- Cancer survivorship and care
- Oral and gingival health research
- Pain Mechanisms and Treatments
- Trigeminal Neuralgia and Treatments
- Laser Applications in Dentistry and Medicine
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Osteomyelitis and Bone Disorders Research
- Pain Management and Opioid Use
- Salivary Gland Disorders and Functions
- Tumors and Oncological Cases
- Hepatocellular Carcinoma Treatment and Prognosis
- Lymphoma Diagnosis and Treatment
- Migraine and Headache Studies
- Chemotherapy-related skin toxicity
- Boron and Carbon Nanomaterials Research
- Neuroendocrine regulation and behavior
- Teratomas and Epidermoid Cysts
- Colorectal and Anal Carcinomas
National and Kapodistrian University of Athens
2017-2025
Louisiana State University Health Sciences Center Shreveport
2024
Fondazione Roma
2024
University of the Pacific
2024
Louisiana State University Health Sciences Center New Orleans
2024
General Hospital of Attica
2022
Abstract Head and neck cancer (HNC) patients suffer from a range of health‐related quality life (HRQoL) issues, but little is known about their long‐term HRQoL. This study explored associations between treatment group HRQoL at least 5 years' post‐diagnosis in HNC survivors. In an international cross‐sectional study, survivors completed the European Organization for Research Treatment Cancer (EORTC) core questionnaire (EORTC‐QLQ‐C30) its module (EORTC‐QLQ‐H&N35). Meaningful differences...
We reported the alveolar bone histology prior to dental extractions in cancer patients, who received bone-targeting agents (BTA).Fifty-four patients were included. Patients underwent extractions, and biopsies taken.Extractions performed due pain, swelling, purulence, fistula, numbness, not responding treatment, 40 (group A); asymptomatic, non-restorable teeth, 14 B). Complete jaw histological necrosis was observed 28 of (70%) group A none B (p < .001). The development clinical osteonecrosis...
The long-term problems of head and neck cancer survivors (HNCS) are not well known. In a cross-sectional international study aimed at exploring the quality life in this population, 1114 HNCS were asked to state their two most serious effects. A clinician recorded responses during face-to-face appointments. list 15 example was provided, but free text field also available. total 1033 responded question. frequent 'dry mouth' (DM) (n = 476; 46%), 'difficulty swallowing/eating' (DSE) 408; 40%),...
ABSTRACT Background According to the ICOP 2020, burning mouth syndrome (BMS) is a chronic orofacial pain disorder characterised by an intraoral sensation, which represents main diagnostic criterion. However, some patients experience other symptoms such as xerostomia, taste alterations and globus, without sensation (non‐BMS). Objective This study aims explore non‐BMS distinct subclinical entity comparing classical BMS with this new group of in case–control study, addressing gaps current...
Introduction Trigeminal neuralgia (TN) is a chronic condition characterized by sudden, short episodes of excruciating facial pain affecting one or more branches the trigeminal nerve (V), which severely impacts patients' quality life. Despite availability various treatment options, some cases experience poor control. Sphenopalatine ganglion (SPG) block using Tx360 nasal applicator has recently been introduced with promising results as option in such cases. Materials and methods Fifteen adult...
Pazopanib is a potent multi-kinase inhibitor that hinders angiogenesis and blocks tumor growth. It has been approved for the treatment of metastatic renal cell carcinoma (mRCC) advanced soft tissue sarcoma. There emerging evidence bleeding common adverse effect pazopanib other targeted therapies in patients with mRCC. In addition, jaw osteonecrosis related to was recently described literature. We report three cases mRCC who developed oral events pazopanib. The first patient, treated as...
Abstract Background Patients, who receive radiotherapy (RT) for head and neck cancer, develop chronic functional abnormalities survive with reduced quality of life. Purpose We aimed to study patients oral received post-operative or chemoradiotherapy. Patients Ten (mean age 63.8 years) were included. Methods Oral mucositis, pain xerostomia, maximum mouth opening (MMO) before after RT recorded. The 35 mm MMO less was accepted as trismus. completed the EORTC QLQ C-30 Head/Neck35 questionnaires....
Lipomas are benign tumors of adipose tissue. They represent the most common mesenchymal neoplasm but relatively rare in oral and maxillofacial regions. The purpose this study is to present an unusual case a large lipoma buccal space its excision by intraoral approach. A 38-year-old male patient presented with otherwise asymptomatic swelling right cheek that had first been noticed four years earlier subsequently exhibited gradual, continuous enlargement stable dimensions over last year. was...
Background/Objectives: The etiology of diffuse gingival enlargement is multifactorial, and the definitive diagnosis may be challenging. To highlight nuances differential diagnosis, we present two cases generalized overgrowth discuss diagnostic dilemmas. Case description: In first case, an 82-year-old male with a medical history hypertension prostatitis had chief complaint symptomatic oral lesions 20-day duration, accompanied by fever loss appetite. clinical examination revealed diffusely...
Background: Burkitt lymphoma (BL) is an aggressive non-Hodgkin (NHL), subdivided into endemic, sporadic, and immunodeficiency-associated forms. While jaw lesions are common in endemic BL, they infrequent sporadic cases, only rarely constituting the first manifestation of disease. The aim this study to present a rare pediatric case BL manifesting as gingival swellings tooth hypermobility provide review all published reports sign Case report: An 11-year-old Caucasian female was referred for...
Panitumumab is an anti-epithelial growth factor receptor monoclonal antibody, approved for the treatment of metastatic colorectal cancer. has been more commonly associated with skin toxicity; oral adverse events have scarcely reported in literature. Herein, we present a case report panitumumab-associated aphthous-like stomatitis. A 58 years old female visited Oral Oncology Unit complaining severe pain. The patient had diagnosed colon cancer to liver and was receiving panitumumab (every 14...
The primary aim of this study was to evaluate the activation PERP and Akt oncogenes in induction skin cancer FVB/N mice by a stepwise chemical process. Forty four-week-old female were randomly divided into control group (n = 8) two experimental groups (group A: n 16, B: 16). In study, subjected two-stage carcinogenesis procedure. This consisted an initial application 97.4 nmol DMBA shaved on back, followed applications 32.4 TPA after thirteen weeks for A twenty B. received no treatment. Skin...
Introduction: Head and neck cancer (HNC) patients may experience neuropathic pain (NP) due to radiotherapy (RT), which become chronic. Pregabalin, an anticonvulsant, alters the transmission of painful stimuli at synaptic level, modifying their perception. Pregabalin is used in NP treatment, but limited data exist on RT-treated HNC patients. This retrospective study aimed present a case series with chronic after RT managed pregabalin. Methods: patients' records from Department Oral Medicine...